摘要
单核苷酸多态性(SNP)是第三代分子标记技术,成为当今医学研究最常用的方法之一。随着遗传学、分子生物学的发展,SNP的检测和分析方法趋于多样化,并逐步深入到临床疾病的研究和防治过程中,如代谢综合征。以SNP为基础的基因芯片技术用于筛查代谢综合征快速而准确,得到广泛应用,正逐步取代传统的DNA检测。将SNP检测结果作为参数来构建代谢综合征风险预测模型,从而起到风险预测评估,指导预防疾病发生的作用。同时,代谢综合征关联基因的确定有助于治疗方案的制订。
Single nucleotide polymorphism( SNP) is the third generation of molecular marker technology,which has become one of the most commonly used methods in medical research in recent years. With the development of the genetics and molecular biology,methods of detecting and analyzing SNP tend to be diversified,and gradually apply in the process of clinical research and control of diseases,for example,the metabolic syndrome. The gene chip technology based on SNP is widely used to screen the metabolic syndrome because it's fast and accurate,and it is gradually replacing the traditional DNA test. Using the SNP detection results as parameters to build the metabolic syndrome risk prediction model is helpful to the risk prediction assessment and guidance of disease precaution. At the same time,the identification of metabolic syndrome associated genes contributes to the formulation of treatment plans.
出处
《医学综述》
2014年第22期4155-4157,共3页
Medical Recapitulate
关键词
单核苷酸多态性
代谢综合征
脂联素
基因芯片
风险预测模型
Single nucleotide polymorphism
Metabolic syndrome
Adiponectin
Gene chips
Risk prediction mode